Peptides as key components in the design of non-viral vectors for gene delivery

被引:6
|
作者
Thomas, Joseph [1 ]
Punia, Kamia [1 ]
Montclare, Jin Kim [1 ,2 ,3 ,4 ]
机构
[1] New York Univ Tandon, Dept Chem & Biomol Engn, Sch Engn, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Biochem, Brooklyn, NY 11203 USA
[3] NYU, Dept Chem, New York, NY USA
[4] NYU, Coll Dent, Dept Biomat, New York, NY USA
基金
美国国家卫生研究院;
关键词
biomaterials; gene delivery; peptide; polypeptide; nucleic acid; CELL-PENETRATING PEPTIDES; IN-VIVO; PROTEIN TRANSDUCTION; TAT-PEPTIDE; ENDOTHELIAL-CELLS; ENDOSOMAL ESCAPE; SIRNA DELIVERY; GROWTH-FACTOR; PLASMID DNA; CANCER;
D O I
10.1002/pep2.24189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Successful clinical implementation of gene delivery relies on the use of viral or non-viral based vectors to package and protect the therapeutic nucleic acid. These vehicles must also be able to direct the fate of the cargo once it has entered the cell to ensure that the nucleic acid is functional, and the desired outcome is achieved. Compared to viral vectors, non-viral vectors have the advantage of incorporating different material types such as lipids, polymers, and peptides to tune overall safety and efficacy. Peptides are especially powerful when used in gene delivery vectors as they are able to increase gene delivery efficacy by introducing new biochemical functionality. This review will discuss the use of peptides as central design components in non-viral gene delivery vectors. The contribution of the peptide component to the overall functionality of the delivery vehicle will be highlighted, with a focus on peptides as the only vehicle component or peptides in complex assemblies with lipids or polymers.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] In vivo gene delivery mediated by non-viral vectors for cancer therapy
    Mohammadinejad, Reza
    Dehshahri, Ali
    Madamsetty, Vijay Sagar
    Zahmatkeshan, Masoumeh
    Tavakol, Shima
    Makvandi, Pooyan
    Khorsandi, Danial
    Pardakhty, Abbas
    Ashrafizadeh, Milad
    Afshar, Elham Ghasemipour
    Zarrabi, Ali
    JOURNAL OF CONTROLLED RELEASE, 2020, 325 : 249 - 275
  • [2] Application of Non-Viral Vectors in Drug Delivery and Gene Therapy
    Ren, Shuaikai
    Wang, Mengjie
    Wang, Chunxin
    Wang, Yan
    Sun, Changjiao
    Zeng, Zhanghua
    Cui, Haixin
    Zhao, Xiang
    POLYMERS, 2021, 13 (19)
  • [3] Cyclodextrins in non-viral gene delivery
    Lai, Wing-Fu
    BIOMATERIALS, 2014, 35 (01) : 401 - 411
  • [4] Development of non-viral vectors for systemic gene delivery
    Liu, F
    Huang, L
    JOURNAL OF CONTROLLED RELEASE, 2002, 78 (1-3) : 259 - 266
  • [5] Strategies for cancer gene-delivery improvement by non-viral vectors
    Santana-Armas, Maria L.
    de Ilarduya, C. Tros
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 596
  • [6] Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
    Caffery, Breanne
    Lee, Jeoung Soo
    Alexander-Bryant, Angela A.
    NANOMATERIALS, 2019, 9 (01)
  • [7] Viral and non-viral vectors for cancer gene therapy
    Cristiano, RJ
    ANTICANCER RESEARCH, 1998, 18 (5A) : 3241 - 3245
  • [8] Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer
    Kanvinde, Shrey
    Kulkarni, Tanmay
    Deodhar, Suyash
    Bhattacharya, Deep
    Dasgupta, Aneesha
    BIOTECH, 2022, 11 (01):
  • [9] Delivery of Biomolecules with Non-Viral Vectors
    Biri, Stephanie
    Stock, Fabrice
    Adib, Abdennaji
    Erbacher, Patrick
    CELLS AND CULTURE, 2010, 4 : 115 - 119
  • [10] Synthetic peptides as non-viral DNA vectors
    Fabre, John W.
    Collins, Louise
    CURRENT GENE THERAPY, 2006, 6 (04) : 459 - 480